Innovating Works

SUCCIPRO SL

Activa
SUCZYME: VALORISATION AND OPTIMIZATION OF NOVEL FIRST-IN CLASS SUCCINATE-DEPLETING THERAPIES SUCCIPRO SL tramitó un HORIZON EUROPE: HORIZON-EIE-2022-SCALEUP-02-02 SUCCIPRO is a spin-off company from Pere Virgili Health Institute and Rovira Virgili University. It is an early-stage drug development comp...
2023-06-01 - 2024-01-31 | Financiado
DENDRIMAGE: Luminescent lanthanide dendrimer imaging agents for detection of cancer cells and tumors in vivo CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS tramitó un FP7: "Luminescence is an attractive strategy for a low cost, real-time and unambiguous detection of cancer cells and tumors due to its high sensi...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.